Signals

CVKD

24 in-universe funds with a nonzero position in CVKD within the trailing 4 quarters, as of 2026Q1

Catalyst Timeline merged from Insider (Form 4), 8-K and Ownership/dilution filings already on file -- not a live news feed Full insider history

DateTypeWhat happened
2026-08-31 8-K Item(s) 7.01, 8.01, 9.01
2026-08-13 8-K Item(s) 2.02, 9.01
2026-07-21 8-K Item(s) 7.01, 8.01, 9.01
2026-07-17 8-K Item(s) 5.02, 9.01
2026-07-15 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (D)
2026-07-13 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (S-3)
2026-07-10 8-K Item(s) 5.02, 9.01
2026-07-01 8-K Item(s) 1.01, 3.02, 8.01, 9.01
2026-06-29 8-K Item(s) 5.02, 9.01
2026-06-18 8-K Item(s) 7.01, 8.01, 9.01
2026-06-03 8-K Item(s) 5.02, 9.01
2026-05-07 8-K Item(s) 2.02, 9.01
2026-04-21 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (S-3)
2026-04-06 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (D)
2026-04-01 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (424B5)
2025-12-31 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (D)
2025-12-23 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (424B5)
2025-12-16 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (424B5)
2025-12-16 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (424B5)
2025-11-18 Ownership Dilution filing by Cadrenal Therapeutics, Inc. (424B5)

Flow ranking

Rank#15002
Score / z0.000 / -0.02
Consensus6.64 over 10 funds
Momentumnot computed

Price & positioning

224 cached closes, trailing year
Drawdownnot computed
Short interestnot computed

Forensics

No XBRL fundamentals on file for this issuer — either not backfilled yet, or a financial/REIT excluded from these ratios. Not the same as clean.

Insider

No Form 4 activity on file for this ticker.

8-K events

Negative / total0 / 7
FiledFormItems
2026-08-31 8-K 7.01, 8.01, 9.01
2026-08-13 8-K 2.02, 9.01
2026-07-21 8-K 7.01, 8.01, 9.01
2026-07-17 8-K 5.02, 9.01
2026-07-10 8-K 5.02, 9.01
2026-07-01 8-K 1.01, 3.02, 8.01, 9.01
2026-06-29 8-K 5.02, 9.01
2026-06-18 8-K 7.01, 8.01, 9.01
2026-06-03 8-K 5.02, 9.01
2026-05-07 8-K 2.02, 9.01
Showing the 10 most recent.

Ownership

13D / 13G / dilution0 / 0 / 5
FiledFormFiler
2026-07-15 D Cadrenal Therapeutics, Inc.
2026-07-13 S-3 Cadrenal Therapeutics, Inc.
2026-04-21 S-3 Cadrenal Therapeutics, Inc.
2026-04-06 D Cadrenal Therapeutics, Inc.
2026-04-01 424B5 Cadrenal Therapeutics, Inc.
2025-12-31 D Cadrenal Therapeutics, Inc.
2025-12-23 424B5 Cadrenal Therapeutics, Inc.
2025-12-16 424B5 Cadrenal Therapeutics, Inc.
2025-12-16 424B5 Cadrenal Therapeutics, Inc.
2025-11-18 424B5 Cadrenal Therapeutics, Inc.
Showing the 10 most recent.

LLM reads

Ticker Eval hasn't reached this ticker yet. It's gated to the top of the ranking, so this is an ordering artefact, not a judgement.
Quarter
Fund AUM ($M)
Fund Positions
Quarters Held

Fund holders

Fund Quality Q Positions Value ($M) % of Fund AUM Qtrs Held Δ 1Q Δ 2Q Δ 3Q Δ 4Q
GEODE CAPITAL MANAGEMENT, LLC CIK 0001214717 0.990 4447 0.1 0.0% 4 +0.0 pp -0.0 pp -0.0 pp +0.0 pp
VANGUARD FIDUCIARY TRUST CO CIK 0000933478 0.000 4076 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
BlackRock, Inc. (BLK) CIK 0002012383 0.995 5652 0.0 0.0% 4 +0.0 pp -0.0 pp -0.0 pp +0.0 pp
Cygnus Capital Advisors, LLC CIK 0002114319 0.011 74 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Tower Research Capital LLC (TRC) CIK 0001533421 0.051 5180 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
OSAIC HOLDINGS, INC. CIK 0001677044 0.882 7705 0.0 0.0% 5 -0.0 pp -0.0 pp -0.0 pp -0.0 pp
Destiny Wealth Partners, LLC CIK 0001844369 0.190 184 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Rockefeller Capital Management L.P. CIK 0001739439 0.891 4732 0.0 0.0% 3 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) CIK 0000895421 0.985 8402 0.0 0.0% 6 -0.0 pp -0.0 pp -0.0 pp -0.0 pp
WELLS FARGO & COMPANY/MN (WFC, WFCNP, WFC-PA, WFC-PC, WFC-PD, WFC-PL, WFC-PY, WFC-PZ) CIK 0000072971 0.967 6822 0.0 0.0% 4 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
Archer Investment Corp CIK 0001803804 0.301 1254 0.0 0.0% 4 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
IFP Advisors, Inc CIK 0001641866 0.492 5147 0.0 0.0% 4 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
UBS Group AG (UBS) CIK 0001610520 0.954 9044 0.0 0.0% 4 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
CITIGROUP INC (C, C-PN, C-PR) CIK 0000831001 0.924 4888 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
CURIO WEALTH, LLC CIK 0002049201 0.749 78 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
LPL Financial LLC CIK 0001403438 0.957 5996 0.0 0.0% 0 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
VANGUARD GROUP INC CIK 0000102909 0.000 0 0.0 0.0% 0 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
RAYMOND JAMES FINANCIAL INC (RJF) CIK 0000720005 0.962 5261 0.0 0.0% 0 +0.0 pp +0.0 pp -0.0 pp +0.0 pp
JONES FINANCIAL COMPANIES LLLP CIK 0000815917 0.984 4961 0.0 0.0% 0 +0.0 pp -0.0 pp -0.0 pp +0.0 pp
Clearstead Advisors, LLC CIK 0000842775 0.687 3646 0.0 0.0% 0 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
HARBOUR INVESTMENTS, INC. CIK 0000810121 0.643 4768 0.0 0.0% 0 -0.0 pp -0.0 pp -0.0 pp +0.0 pp
CITADEL ADVISORS LLC CIK 0001423053 0.482 6351 0.0 0.0% 0 +0.0 pp -0.0 pp +0.0 pp +0.0 pp
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) CIK 0000019617 0.981 6818 0.0 0.0% 0 -0.0 pp -0.0 pp +0.0 pp +0.0 pp
BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BAC-PQ, BAC-PS, BML-PG, BML-PL) CIK 0000070858 0.982 5665 0.0 0.0% 0 -0.0 pp -0.0 pp -0.0 pp -0.0 pp
Value and % of AUM are this fund's own disclosed long-equity book (13F does not report true firm AUM). Positions is the fund's total position count (all tickers, not just CVKD). Qtrs Held counts distinct quarters this fund has actually held CVKD (weight > 0), across every period we've rescored. Fund AUM and Positions filters apply to the fund's whole book, not its CVKD position size. Δ columns are the percentage-point change in CVKD's weight within each fund's book vs. the trailing 1/2/3/4 quarters (2025Q4 / 2025Q3 / 2025Q2 / 2025Q1) — a fund not yet holding it that far back is treated as 0%. Only in-universe (quality-scored) funds are shown, matching the Signals-tab methodology.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status